12,372 trials
Acute Myelogenous Leukemia · Myelodysplastic Syndrome · Leukemia
Primary: Median Number of Participant Transfusions Required During 12 Weeks of Treatment — 7; 7 Transfusions per Participant
Endometrial Hyperplasia · Osteoporosis
Primary: Percentage of Participants With Hyperplasia at Screening
Menopause · Osteoporosis
Primary: Percentage of Participants With Endometrial Hyperplasia at Month 12: Main Study — 0.30; 0.54; 0.00; 0.00 Percentage of Participants
Typical Atrial Flutter
Primary: Primary Safety- Incidence of Intra Procedural Serious Cardiac Adverse Events Occuring Within 7 Days of Post-procedure, Regardless of Whether a Determination Can be Made…
Asthma
Primary: Mean Change From Baseline (BL) in Daily Evening (PM) Peak Expiratory Flow (PEF) Averaged Over the 12-week Treatment Period — 39.1; 10.5 Liters/minute (L/min) — p=<0.001
Influenza
Primary: Seroprotection — 65.5; 80.0; 98.2; 98.2 percentage of subjects
Schizoaffective Disorder · Schizophrenia
Primary: Hospitalization-free Survival - Time to Event — NA; 1.97 years — p=0.39
Nasal Polyps
Primary: Change From Baseline in Congestion/Obstruction Score — -0.56; -0.42 score on a scale — p=0.0007
Other Acute Postoperative Pain
Primary: The Time-Weighted Summed Pain Intensity Difference Measured Using the 100-mm Visual Analogue Scale From 0 to 48 Hours After Trial Entry (VASSPID-48), ANCOVA Model…
Ovarian Cancer
Primary: Investigator-assessed Progression-free Survival (PFS) — 12.3; 17.9 months — p=0.0021
Alzheimer's Disease · Mild Cognitive Impairment
Primary: Summary of Sensitivity of the Blinded Visual PET Image Interpretations Without Anatomic Images. — 94; 92; 90; 94 Percentage (True Positive)
Other Acute Postoperative Pain
Primary: The Time-Weighted Summed Pain Intensity Difference Measured Using the 100-mm Visual Analogue Scale From 0 to 48 Hours After Trial Entry (VASSPID-48) — 508.2; 329.8…
Depressive Disorder, Major
Primary: Change From Baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score — -10.77; -12.96; -14.41 scores on a scale — p=0.058
Generalized Anxiety Disorder
Primary: Change From Baseline in the Hamilton Anxiety (HAM-A) Scale Total Score at Week 8 — -11.27; -12.23; -11.57; -11.66 scores on a scale — p=0.255
Depressive Disorder, Major
Primary: Change From Baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score — -12.87; -13.66; -13.36 scores on a scale — p=0.597